Building a new strategy for treating heart failure using Induced Pluripotent Stem Cells
- 29 August 2018
- journal article
- review article
- Published by Elsevier BV in Journal of Cardiology
- Vol. 72 (6), 445-448
- https://doi.org/10.1016/j.jjcc.2018.05.002
Abstract
No abstract availableKeywords
Funding Information
- Japan Agency for Medical Research and Development
This publication has 41 references indexed in Scilit:
- Building a bridge to recovery: the pathophysiology of LVAD-induced reverse modeling in heart failureSurgery Today, 2015
- Derivation of Highly Purified Cardiomyocytes from Human Induced Pluripotent Stem Cells Using Small Molecule-modulated Differentiation and Subsequent Glucose StarvationJournal of Visualized Experiments, 2015
- Continue what we are doing to treat HF, but do it betterNature Reviews Cardiology, 2013
- Direct somatic cell reprogramming: treatment of cardiac diseases.Current Gene Therapy, 2013
- Technological Overview of iPS Induction from Human Adult Somatic CellsCurrent Gene Therapy, 2013
- In Vivo Differentiation of Induced Pluripotent Stem Cell-Derived CardiomyocytesCirculation Journal, 2013
- A Small Molecule that Promotes Cardiac Differentiation of Human Pluripotent Stem Cells under Defined, Cytokine- and Xeno-free ConditionsCell Reports, 2012
- Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived populationNature, 2008
- Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined FactorsCell, 2006
- Tissue Cardiomyoplasty Using Bioengineered Contractile Cardiomyocyte Sheets to Repair Damaged Myocardium: Their Integration with Recipient MyocardiumTransplantation, 2005